# Double Therapy With IFN-beta 1b and Hydroxychloroquine

> **NCT04350281** · PHASE2 · COMPLETED · sponsor: **The University of Hong Kong** · enrollment: 60 (actual)

## Conditions studied

- COVID

## Interventions

- **DRUG:** Interferon Beta-1B
- **DRUG:** Hydroxychloroquine

## Key facts

- **NCT ID:** NCT04350281
- **Lead sponsor:** The University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-09
- **Primary completion:** 2020-07-01
- **Final completion:** 2020-07-07
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2020-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04350281

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04350281, "Double Therapy With IFN-beta 1b and Hydroxychloroquine". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04350281. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*